Cognitive and affective impairments of a novel SCA/MND crossroad mutation Asidan

European Journal of Neurology

Volumn 19, Issue 8, 2012, Pages 1070-1078

  Abe, K ^a   Ikeda, Y ^a   Kurata, T ^a   Ohta, Y ^a   Manabe, Y ^a   Okamoto, M ^a,b   Takamatsu, K ^a,b   Ohta, T ^a,b   Takao, Y ^c   Shiro, Y ^a   Shoji, M ^a   Kamiya, T ^a   Kobayashi, H ^d   Koizumi, A ^d  

^a OKAYAMA UNIVERSITY   (Japan)

^b Ohta Memorial Hospital   (Japan)

^c Kurashiki Heisei Hospital   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Asidan; Cognitive and affective functions; Hexanucleotide GGCCTG expansion; Motor neuron disease; Spinocerebellar ataxia

Indexed keywords

CYTOSINE; GUANINE; THYMINE;

ADULT; AFFECTIVE PSYCHOSIS; AGED; APATHY; ARTICLE; ASIAN; BRAIN BLOOD FLOW; BRAIN CORTEX; CLINICAL ARTICLE; CLINICAL EXAMINATION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEPRESSION; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; JAPANESE; MALE; MINI MENTAL STATE EXAMINATION; MOTOR NEURON DISEASE; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINOCEREBELLAR DEGENERATION;

AGE OF ONSET; AGED; COGNITION DISORDERS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; MUTATION; NEUROPSYCHOLOGICAL TESTS; NUCLEAR PROTEINS; SPINOCEREBELLAR ATAXIAS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84863866277     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03669.x     Document Type: Article

References (64)

1. Kameya T, Abe K, Aoki M, et al. Analysis of spinocerebellar ataxia type 1 (SCA1)-related CAG trinucleotide expansion in Japan. Neurology 1995; 45: 1587-1594.
2. Kameya T, Abe K, Aoki M, Itoyama Y. A family with mild clinical manifestations of spinocerebellar ataxia type 1 (SCA1): correlation with smaller CAG repeats. Eur J Neurol 1995; 2: 349-355.
3. Watanabe M, Abe K, Aoki M, et al. Analysis of CAG trinucleotide expansion associated with Machado-Joseph disease. J Neurol Sci 1996; 136: 101-107.
4. Mizushima K, Watanabe M, Abe K, et al. Analysis of spinocerebellar ataxia type 2 in Gunma prefecture in Japan; CAG trinucleotide expansion and clinical characteristics. J Neurol Sci 1998; 156: 180-185.
5. Shizuka M, Watanabe M, Ikeda Y, et al. Spinocerebellar ataxia type 6: CAG trinucleotide expansion, clinical characteristics and sperm analysis. Eur J Neurol 1998; 5: 381-388.
6. Schmitz-Hübsch T, Coudert M, Bauer P, et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology 2008; 23: 71.
7. Bürk K, Bosch S, Globas C, et al. Executive dysfunction in spinocerebellar ataxia type 1. Eur Neurol 2001; 46: 43-48.
8. Storey E, Forrest SM, Shaw JH, Mitchell P, Gardner RJ. Spinocerebellar ataxia type 2: clinical features of a pedigree displaying prominent frontal-executive dysfunction. Arch Neurol 1999; 56: 43-50.
9. La Pira F, Zappala G, Saponara R, et al. Cognitive findings in spincerebellar ataxia type 2: relationship to genetic and clinical variables. J Neurol Sci 2002; 201: 53-57.
10. Maruff P, Tyler P, Burt T, Currie B, Burns C, Currie J. Cognitive deficits in Machado-Joseph disease. Ann Neurol 1996; 40: 421-427.
11. Zawacki TM, Grace J, Friedman JH, Sudarsky L. Executive emotional dysfunction in Machado-Joseph disease. Mov Disord 2002; 17: 1004-1010.
12. Kawai Y, Takeda A, Abe Y, Washimi Y, Tanaka F, Sobue G. Cognitive impairments in Machado-Joseph disease. Arch Neurol 2004; 61: 1757-1760.
13. Sasaki H, Kojima H, Yabe I, et al. Neuropathological and molecular studies of spinocerebellar ataxia type 6. Acta Neuropathol 1998; 95: 199-204.
14. Globas C, Bosch S, Zuhlke C, Daum I, Dichgans J, Burk K. The cerebellum and cognition. Intellectual function in spinocerebellar ataxia type 6 (SCA6). J Neurol 2003; 250: 1482-1487.
15. Suenaga M, Kawai Y, Watanabe H, et al. Cognitive impairment in spinocerebellar ataxia type 6. J Neurol Neurosurg Psychiatr 2008; 79: 496-499.
16. Abe K, Aoki M, Ikeda M, et al. Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn SOD gene mutations. J Neurol Sci 1996; 136: 108-116.
17. Abrahams S, Leigh PN, Goldstein LH. Cognitive change in ALS: a prospective study. Neurology 2005; 64: 1222-1226.
18. Goldstein LH, Atkins L, Landau S, Brown RG, Leigh PN. Longitudinal predictors of psychological distress and self-esteem in people with ALS. Neurology 2006; 67: 1652-1658.
19. Manabe Y, Shiro Y, Takahashi K, Kashihara K, Abe K. A case of spinocerebellar ataxia accompanied by severe involvement of the motor neuron system. Neurol Res 2000; 22: 567-570.
20. Ohta Y, Hayashi T, Nagai M, et al. Two cases of spinocerebellar ataxia accompanied by involvement of the skeletal motor neuron system and bulbar palsy. Intern Med 2007; 46: 751-755.
21. Kobayashi H, Abe K, Matsuura T, et al. Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement. Am J Hum Genet 2011 2007; 89: 121-130.
22. Rasmussen A, Matsuura T, Ruano L, et al. Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. Ann Neurol 2001; 50: 234-239.
23. Lin X, Ashizawa T. Recent progress in spinocerebellar ataxia type-10 (SCA10). Cerebellum 2005; 4: 37-42.
24. Sato N, Amino T, Kobayashi K, et al. Spinocerebellar ataxia type 31 is associated with "inserted" penta-nucleotide repeats containing (TGGAA)n. Am J Hum Genet 2009; 85: 544-557.
25. Sreedharan J, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008; 319: 1668-1672.
26. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009; 323: 1205-1208.
27. Vance C, Rogelj B, Hortobágyi T, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009; 323: 1208-1211.
28. Schmitz-Hübsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006; 66: 1717-1720.
29. Schmitz-Hübsch T, Tezenas du Montcel S, Baliko L, Bosch S, Bonato S, Fancellu R. Reliability and validity of the International Cooperative Ataxia rating Scale: a study in 156 spinocerebellar ataxia patients. Mov Disord 2006; 21: 699-704.
30. Folstein MF, Folstein SE, McHugh PR. Mini mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
31. Kato S, Shimogaki M, Onodera H. Revised HasegawaDementia Scale (HDS-R). Jpn J Geriatr Psychiatry 1991; 2: 1339-1347.
32. Arvanitakis Z, Tounsi H, Pillon B, Dubois B. Les démences fronto-temporales: approche clinique. Rev Neurol (Paris) 1999; 155: 113-119.
33. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB-a frontal assessment battery at beside. Neurology 2000; 55: 1621-1626.
34. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699.
35. Lesher EL, Berryhill JS. Validation of the Geriatric Depression Scale-Short Form among inpatients. J Clin Psychol 1994; 50: 256-260.
36. Toba K, Nakai R, Akishita M, Ouchi Y. Vitality index as a useful tool for assess elderly with dementia. Geriatr Gerontol Int 2002; 2: 23-29.
37. Starkstein SE, Fedoroff JP, Price TR, Leiguarda R, Robinson RG. Apathy following cerebrovascular lesions. Stroke 1993; 24: 1625-1630.
38. Okada K, Kobayashi S, Yamagata S, Takahashi K, Yamaguchi S. Poststroke apathy and regional cerebral blood flow. Stroke 1997; 28: 2437-2441.
39. Waragai M, Yamada T, Matsuda H. Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases. J Neurol Sci 2007; 260: 57-64.
40. Schmahmann JD. An emerging concept: the cerebellar contribution to higher function. Arch Neurol 1991; 48: 1178-1187.
41. Grafman J, Litvan I, Massaquoi S, Stewart M, Sirgu A, Hamlett M. Cognitive planning deficit in patients with cerebellar atrophy. Neurology 1992; 42: 1493-1496.
42. Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain 1998; 121: 561-579.
43. Gottwald B, Wilde B, Mihajlovic Z, Mehdorn HM. Evidence for distinct cognitive deficits after focal cerebellar lesions. J Neurol Neurosurg Psychiatr 2004; 75: 1524-1531.
44. Bürk K. Cognition in hereditary ataxia. Cerebellum 2007; 6: 280-286.
45. Kawai Y, Suenaga M, Watanabe H, Sobue G. Cognitive impairment in spinocerebellar degeneration. Eur Neurol 2009; 61: 257-268.
46. Bürk K, Globas C, Bosch S, et al. Cognitive deficits in spinocerebellar ataxia type 1, 2 and 3. J Neurol 2003; 250: 207-211.
47. Garrard P, Martin NH, Giunti P, Cipolotti L. Cognitive and social cognitive functioning in spinocerebellar ataxia: a preliminary characterization. J Neurol 2008; 255: 398-405.
48. Klinke I, Minnerop M, Schmitz-Hübsch T, et al. Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6. Cerebellum 2010; 9: 433-442.
49. Abrahams S, Leigh PN, Kew JJ, Goldstein LH, Lloyd CM, Brooks DJ. A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis. J Neurol Sci 1995; 129(Suppl.): 44-46.
50. Abrahams S, Goldstein LH, Lloyd CM, Brooks DJ, Leigh PN. Cognitive deficits in non-demented amyotrophic lateral sclerosis patients: a neuropsychological investigation. J Neurol Sci 1995; 129(Suppl.): 54-55.
51. Crowne DP. A new scale of social desirability independent of psychopathology. J Consult Psychol 1960; 24: 349-354.
52. Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70.
53. Abe K, Itoyama Y. Psychological consequences of genetic testing for spinocerebellar ataxia in the Japanese. Eur J Neurol 1997; 4: 593-600.
54. Woolley SC, Moore DH, Katz JS. Insight in ALS: awareness of behavioral change in patients with and without FTD. Amyotroph Lateral Scler 2010; 11: 52-56.
55. Palmieri A, Abrahams S, Sorarù G, et al. Emotional lability in MND: relationship to cognition and psychopathology and impact on caregivers. J Neurol Sci 2009; 278: 16-20.
56. Meininger V. Treatment of emotional lability in ALS. Lancet Neurol 2005; 4: 70.
57. Taylor L, Wicks P, Leigh PN, Goldstein LH. Prevalence of depression in amyotrophic lateral sclerosis and other motor disorders. Eur J Neurol 2010; 17: 1047-1053.
58. Wicks P, Abrahams S, Papps B, et al. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis. J Neurol 2009; 256: 234-241.
59. Vercelletto M, Ronin M, Huvet M, Magne C, Feve JR. Frontal type dementia preceding amyotrophic lateral sclerosis: a neuropsychological and SPECT study of five clinical cases. Eur J Neurol 1999; 6: 295-299.
60. Ishikawa T, Morita M, Nakano I. Constant blood flow reduction in premotor frontal lobe regions in ALS with dementia - a SPECT study with 3D-SSP. Acta Neurol Scand 2007; 116: 340-344.
61. Rusina R, Ridzon P, Kulist'ák P, et al. Relationship between ALS and the degree of cognitive impairment, markers of neurodegeneration and predictors for poor outcome. A prospective study. Eur J Neurol 2010; 17: 23-30.
62. Decety J, Sjoholm H, Ryding E, Stenberg G, Ingvar DH. The cerebellum participates in mental activities: tomographic measurement of regional cerebral blood flow. Brain Res 1990; 535: 313-317.
63. Allen G, Buxton RB, Wong EC, Courchesne E. Attentional activation of the cerebellum independent of motor involvement. Science 1997; 275: 1940-1943.
64. Schlosser R, Hutchinson M, Joseffer S, et al. Functional magnetic resonance imaging of human brain activity in a verbal fluency task. J Neurol Neurosurg Psychiatr 1998; 64: 492-498.